Patent · US Active

Benzimidazole vascular damaging agents

US7875727B2 · kind B2 · utility

4Cited by
6References
31Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJul 11, 2006
Grant dateJan 25, 2011
Priority date
Expiry dateOct 24, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D235/32
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Vascular damaging agents composed of substituted 5(6)-substituted benzimidazole-2-carbamates are provided. These agents are useful in the preparation of medicaments for the treatment of diseases involving neovascularisation, particularly for the treatment of solid tumors, macular degeneration, diabetic retinopathy, rheumatoid arthritis, psoriasis, and atherosclerosis. Embodiments include a 5(6)-substituted benzimidazole-2-carbamate of formula Iwherein A represents a multi-substituted alkyl group or aromatic ring.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.